These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12871443)

  • 1. Thalidomide and thrombosis in multiple myeloma.
    Barbui T; Falanga A
    J Thromb Haemost; 2003 Mar; 1(3):421-2. PubMed ID: 12871443
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making.
    Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G
    Thromb Haemost; 2004 Apr; 91(4):834-6. PubMed ID: 15045155
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.
    Rus C; Bazzan M; Palumbo A; Bringhen S; Boccadoro M
    J Thromb Haemost; 2004 Nov; 2(11):2063-5. PubMed ID: 15550053
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial thrombosis in four patients treated with thalidomide.
    Scarpace SL; Hahn T; Roy H; Brown K; Paplham P; Chanan-Khan A; van Besien K; McCarthy PL
    Leuk Lymphoma; 2005 Feb; 46(2):239-42. PubMed ID: 15621807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide and thrombosis.
    Mehta P
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombosis in multiple myeloma (MM).
    Cesarman-Maus G; Braggio E; Fonseca R
    Hematology; 2012 Apr; 17 Suppl 1(0 1):S177-80. PubMed ID: 22507814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of thrombosis in multiple myeloma.
    Leebeek FW
    Thromb Res; 2016 Apr; 140 Suppl 1():S76-80. PubMed ID: 27067983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and thrombosis in patients with multiple myeloma.
    Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M
    Haematologica; 2001 Oct; 86(10):1108-9. PubMed ID: 11602422
    [No Abstract]   [Full Text] [Related]  

  • 10. Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs.
    Paydas S
    Leuk Lymphoma; 2008 Aug; 49(8):1644-5. PubMed ID: 18766977
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide in multiple myeloma: state of art.
    Tosi P; Cavo M
    Haematologica; 2002 Mar; 87(3):233-4. PubMed ID: 11869932
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloma, thalidomide and thrombosis.
    Hönemann D; Prince HM
    Leuk Lymphoma; 2006 Nov; 47(11):2273-5. PubMed ID: 17107896
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin as thromboprophylaxis in myeloma.
    Niesvizky R; Martínez-Baños DM
    Leuk Lymphoma; 2008 Aug; 49(8):1646-7. PubMed ID: 18766978
    [No Abstract]   [Full Text] [Related]  

  • 14. Arterial thrombosis and thalidomide.
    Goz M; Eren MN; Cakir O
    J Thromb Thrombolysis; 2008 Apr; 25(2):224-6. PubMed ID: 17514361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboprophylaxis in patients with multiply myeloma who receives chemotherapy with thalidomide].
    Novosad OI; Kriachok IA; Kadnikova TV; Filonenko KS; Tytorenko IB; Martynchyk AV; Aleksyk OM; Gusachenko IuO; Filonenko IA
    Lik Sprava; 2011; (3-4):44-50. PubMed ID: 22416363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left atrial thrombus in multiple myeloma treated with thalidomide].
    Jégo C; Barbou F; Laurent P; Gisserot O; Cellarier G; Bonal J; Bouchiat C; Landais C; de Jaureguiberry JP; Dussarat GV
    Arch Mal Coeur Vaiss; 2003 Oct; 96(10):1006-10. PubMed ID: 14653064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
    Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
    Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we screen patients for inherited thrombophilia before starting thalidomide?
    Otrock ZK; Mahfouz RA; El-Hajj II; Harb MI; Sawaya RA
    Am J Clin Oncol; 2006 Feb; 29(1):100-1. PubMed ID: 16462512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide for the treatment of relapsed and refractory multiple myeloma.
    Cool RM; Herrington JD
    Pharmacotherapy; 2002 Aug; 22(8):1019-28. PubMed ID: 12173786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide.
    Chow S; Cheung CS; Lee DH; Howson-Jan K; Xenocostas A
    Leuk Lymphoma; 2012 May; 53(5):1003-5. PubMed ID: 22054288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.